SonoVascular, Inc.
SonoVascular is a medical technology company focused on developing innovative ultrasound-based solutions for vascular care, particularly targeting venous thromboembolism (VTE). Their flagship product, SonoThrombectomy™, aims to provide a safer, more effective, and less expensive interventional treatment for VTE, disrupting current thrombolysis and thrombectomy methods.
Industries
Nr. of Employees
small (1-50)
SonoVascular, Inc.
Chapel Hill, North Carolina, United States, North America
Products
Therapeutic ultrasound-based catheter system for clot debulking
An investigational intravascular catheter system that delivers therapeutic ultrasound, used with exogenous microbubbles, to mechanically debulk venous thrombus in a cath-lab single-session procedure.
Therapeutic ultrasound-based catheter system for clot debulking
An investigational intravascular catheter system that delivers therapeutic ultrasound, used with exogenous microbubbles, to mechanically debulk venous thrombus in a cath-lab single-session procedure.
Services
Early-phase investigational clinical programs for endovascular devices
Design and execution of first-in-human and early clinical studies for investigational ultrasound-based endovascular therapies targeting venous thromboembolism.
Strategic development partnerships for agent-device combination therapies
Collaborative development agreements to integrate exogenous microbubble agents with ultrasound-mediated device therapies for thrombus treatment.
Early-phase investigational clinical programs for endovascular devices
Design and execution of first-in-human and early clinical studies for investigational ultrasound-based endovascular therapies targeting venous thromboembolism.
Strategic development partnerships for agent-device combination therapies
Collaborative development agreements to integrate exogenous microbubble agents with ultrasound-mediated device therapies for thrombus treatment.
Expertise Areas
- Interventional vascular therapy for venous thromboembolism
- Early-phase clinical study execution (first-in-human studies)
- Therapeutic ultrasound and cavitation methods
- Preclinical efficacy testing in large-animal thrombosis models
Key Technologies
- Therapeutic ultrasound
- Microbubble-enhanced cavitation
- Catheter-based endovascular delivery
- Large-animal (porcine) DVT models